1
|
Details of the person discharging managerial responsibilities/person closely associated
| |
a) | Name | C&F Consulting EURL |
2
|
Reason for the notification
| |
a) | Position/status | Person closely associated; relevant person discharging managerial responsibilities: Dr. Marc Cluzel, Chairman of the Supervisory Board of MorphoSys AG |
b) | Initial notification/Amendment | Initial notification |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) | Name | MorphoSys AG |
b) | LEI | 529900493806K77LRE72 |
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
a) |
Description of the financial instrument. type of instrument
Identification code
| Shares of MorphoSys AG, ISIN DE0006632003 |
b) | Nature of the transaction | Acquisition |
c) | Price(s) and volume(s) |
Price(s) Volume(s) 30.73 € 46,088.85 € |
d) |
Aggregated information Aggregated volume Price |
46,088.85 €
30.73 €
|
e) | Date of the transaction |
2022-01-07; UTC+1
|
f) | Place of the transaction | Xetra |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
MorphoSys AG published this content on 11 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 January 2022 15:17:07 UTC.